Literature DB >> 22109828

Reversible branch retinal artery occlusion following intravenous cisplatin chemotherapy for cervical carcinoma.

Arijit Mitra1, Matthew R Edmunds, Nawaz Walji, Indrajit N Fernando, Robert A H Scott, Peter Good.   

Abstract

Cisplatin (CDDP) is a chemotherapeutic agent widely used to treat solid tumours. We present a case of reversible CDDP-associated branch retinal artery occlusion.

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22109828     DOI： 10.1007/s10792-011-9476-2

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN： 0165-5701            Impact factor:   2.031


  11 in total

1.  Bilateral blindness and lumbosacral myelopathy associated with high-dose carmustine and cisplatin therapy.

Authors:  M Y Wang; A C Arnold; H V Vinters; B J Glasgow
Journal:  Am J Ophthalmol       Date:  2000-09       Impact factor: 5.258

2.  Visual system toxicity following intra-arterial chemotherapy.

Authors:  M J Kupersmith; L P Frohman; I S Choi; S H Foo; E Hiesinger; A Berenstein; A Wise; R E Carr; J Ransohoff
Journal:  Neurology       Date:  1988-02       Impact factor: 9.910

3.  Maculopathy caused by intra-arterially administered cisplatin and intravenously administered carmustine.

Authors:  M J Kupersmith; W H Seiple; K Holopigian; K Noble; E Hiesiger; F Warren
Journal:  Am J Ophthalmol       Date:  1992-04-15       Impact factor: 5.258

4.  Retinal ischemia with neovascularization in cisplatin related retinal toxicity.

Authors:  Anthony S L Kwan; Anjana Sahu; George Palexes
Journal:  Am J Ophthalmol       Date:  2006-01       Impact factor: 5.258

5.  Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell support.

Authors:  D W Johnson; P J Cagnoni; T M Schossau; S M Stemmer; D E Grayeb; A E Baron; E J Shpall; S I Bearman; J McDermitt; R B Jones
Journal:  Bone Marrow Transplant       Date:  1999-10       Impact factor: 5.483

6.  Recurrent peripheral arterial thrombosis induced by cisplatin and etoposide.

Authors:  Rita M Cool; Jon D Herrington; Lucas Wong
Journal:  Pharmacotherapy       Date:  2002-09       Impact factor: 4.705

7.  Retinal toxicity after high-dose cisplatin therapy.

Authors:  G Wilding; R Caruso; T S Lawrence; Y Ostchega; E J Ballintine; R C Young; R F Ozols
Journal:  J Clin Oncol       Date:  1985-12       Impact factor: 44.544

Review 8.  Severe vascular toxicity associated with cisplatin-based chemotherapy.

Authors:  F Içli; H Karaoğuz; D Dinçol; A Demirkazik; N Günel; R Karaoğuz; A Uner
Journal:  Cancer       Date:  1993-07-15       Impact factor: 6.860

9.  Arterial thrombosis after chemotherapy with cisplatin, vinblastine and methotrexate.

Authors:  R G Molloy; G C Welch; J K Drury; B J Abel
Journal:  Br J Clin Pract       Date:  1995 Jan-Feb

10.  [Neurologic complications following intraarterial chemoinfusion and/or chemoembolization of pelvic malignancies].

Authors:  S Morita; T Takemura; S Matsumoto; R Odani
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  1989-06-25
View more
  1 in total

1.  Acute and chronic spectral domain optical coherence tomography features of branch retinal artery occlusion.

Authors:  Ian Aureliano Stephen Rodrigues
Journal:  BMJ Case Rep       Date:  2013-05-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.